Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Rite Aid Corporation : Shares Drop After Yet Another Hiccup in Merger Deal: Today's Research Reports on Rite Aid and Walgreens Boots Alliance

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2017 | 02:01pm CEST

NEW YORK, NY / ACCESSWIRE / April 24, 2017 / Rite-Aid and Walgreens Boots Alliance are now facing yet another twist in the plot to the story of their potential and highly anticipated merger. A report released by Bloomberg on Wednesday indicated that the Federal Trade Commission might sue to block the drugstore chains from merging. Walgreens had been planning to sell up to 1,200 Rite Aid stores to Fred's Pharmacy as a part of an effort to win over FTC approval. The two stocks tumbled after traders worriedly reacted to the Bloomberg report.

RDI Initiates Coverage:

Rite Aid Corporation
https://ub.rdinvesting.com/news/?ticker=RAD

Walgreens Boots Alliance, Inc.
https://ub.rdinvesting.com/news/?ticker=WBA

Rite-Aid shares closed down 4.28% and saw their lowest levels in trading on Friday since September of 2013, hitting as low as $3.76 in intra-day trading. The drugstore chain had been spiraling down since Wednesday when a report from Bloomberg, citing the trade publication Capital Forum, revealed that the FTC may sue to block Rite-Aid from merging with Walgreens Boots Alliance. Walgreens had offered $9 per share originally for Rite Aid but had revised the agreement earlier in January to $6.50 to $7 per share. Investors had been betting heavily for months that Walgreens Boots Alliance would be able to complete its proposed acquisition of rival drugstore chain Rite Aid.

Access RDI's Rite Aid Corporation Research Report at:
https://ub.rdinvesting.com/news/?ticker=RAD

Walgreens shares edged down on Friday, but surprisingly didn't see as negative a reaction as Rite-Aid and Fred's Pharmacy. Traders may be increasingly doubtful that the takeover will ever happen, but seemed pleased by the company's announcement from last week when Walgreens said that its board of directors had declared a regular quarterly dividend of 37.5 cents per share, an increase of 4.2 percent over the year-ago period. The dividend is payable June 12th, 2017 to stockholders of record on May 18th, 2017. Shares closed down 0.13% on Friday.

Access RDI's Walgreens Boots Alliance, Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=WBA

Our Actionable Research on Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com


© Accesswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
02:01p RITE AID CORPORATION : Shares Drop After Yet Another Hiccup in Merger Deal: Toda..
04/22 RITE AID : Elderly man crashed into Rite Aid on 853 Longwood Avenue
04/21 RITE AID : Bail increased for man charged in Rite Aid stabbing
04/20 RITE AID : DreamShip at Spring Carlisle supports the children of fallen heroes
04/17 RITE AID : Fundraiser helps children's hospital
04/15 RITE AID : Police Beat Compiled by Marilyn Baer
04/13 DUKE ENERGY : Business owner scammed out of nearly $5,000 Community raises funds..
04/12 RITE AID CORPORATION : (RAD) Down Ahead of Quarterly Loss
04/10 RITE AID : Position Reduced by Metropolitan Life Insurance Co. NY
04/08 CLEARLAKE POLICE LOGS : Thursday, April 6
More news
Sector news : Retail - Drugs without Grocery
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
04/05DJWalgreens CEO Says Rite Aid Deal Closing Soon -- Update
04/05DJHot Stocks to Watch in the U.S. and Canada
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
09:55a RISK ARBITRAGE TODAY : Rite Aid Reporting
08:43a Consumer sector M&A calendar
04/21 FTC question mark hangs over Rite Aid
04/20 Sinking for Rite Aid
04/20 RISK ARBITRAGE TODAY : More Rite Aid Drama
Advertisement
Financials ($)
Sales 2017 32 597 M
EBIT 2017 456 M
Net income 2017 10,5 M
Debt 2017 6 934 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 0,34x
EV / Sales 2018 0,33x
Capitalization 3 999 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 6,25 $
Spread / Average Target 64%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & CEO-Rite Aid Stores
Bryan B. Everett Executive Vice President-Store Operations
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-53.88%3 999
RAIA DROGASIL SA1.89%6 536
AIN HOLDINGS INC-1.42%2 229
PALTAC CORP12.70%1 814
ORIOLA OYJ-7.19%780
AUSTRALIAN PHARMACEUTI..0.00%761
More Results